The Christie NHS FT Annual Report & Accounts 2019-20

The Christie NHS Foundation Trust Annual Report & Accounts 2019-20

Seeing more clearly: Our strategy

our patients throughout and after their treatment. 3. We will further expand our networked care model and the breadth of services available in the communities to ensure fewer patients have to travel to receive the best care. 4. We will continue to offer the latest technology and develop new treatments for the future, making our data on outcomes of treatments available to the public. We have made huge progress so far and through our ambitious strategy, we aim to further improve across these four pledges. Throughout this report, there are tangible examples of projects helping us achieve our goals and making a real difference to patient care.

We are proud to deliver excellent care to cancer patients from the immediate population of 3.2 million people in the Greater Manchester and Cheshire area, and to a significant number of patients from across the country in need of some highly specialised treatments. We are able to provide a service based on expert staff and a specialised infrastructure dedicated to the delivery of cancer treatment care, research and education. Our focus and size enable us to uniquely deliver effective and efficient specialist care offering patients the best possible outcomes from our research programmes. This is enhanced by the support that we receive from The Christie charity which enables us to provide a level of care and experience for patients above and beyond what is funded by the NHS. Our strategy describes where we want to be as an organisation in the coming years. It was developed throughout 2017/18 following extensive consultation with patients, staff, governors and our board of directors. It sets out a clear vision of how we will transform cancer treatments, care & support and improve outcomes for our patients. Within the strategy, we set ourselves four pledges to prepare for the future. These are: 1. We will continue to lead the development of cancer treatment, research and education so

that by 2025 we will be the leading organisation in the UK in reducing the burden of cancer.

2. We will build on the success of the patient and staff experience recognised by the CQC Outstanding rating. We will go further in understanding and acting upon the needs of

39